Clinical Trial Update: 8-week Pilot Study of Relaxation for Weight Loss in Adults With Chronic Kidney Disease [Phase 3]

View source ↗

Summary

An eight-week relaxation-based weight-loss trial in adults with obesity and chronic kidney disease has completed (Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Edward Hines Jr. VA Hospital | Conditions: Obesity | Phase 3 | Status: COMPLETED